MedTrace Logo

Temporomandibular Joint in Patients With Rheumatoid Arthritis

NCT06134726 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 142

Last updated 2023-11-21

No results posted yet for this study

Summary

the investigators study aimed to evaluate temporomandibular joint involvement in rheumatoid arthritis patients and healthy individuals 142 participants were recruited in two groups: 72 patients with Rheumatoid Arthritis (RA), and 70 healthy controls. All participants were tested for seropositivity of rheumatoid factor and anticitrullinated protein antibodies. TMD diagnosis was determined according to the standardized and validated diagnostic criteria for TMD (DC/TMD): myalgia, arthralgia, articular disc, displacement, degenerative joint disease, and headache attributed to TMD. Bruxism, a probable sleep and/or awake bruxism diagnosis was determined based on self-report and several clinical findings.

Conditions

Interventions

DIAGNOSTIC_TEST

seropositivity of rheumatoid factor

All participants were tested for seropositivity of rheumatoid factor and anticitrullinated protein antibodies

Sponsors & Collaborators

  • Syrian Private University

    lead OTHER

Eligibility

Min Age
35 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-15
Primary Completion
2023-01-01
Completion
2023-01-15

Countries

  • Syria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06134726 on ClinicalTrials.gov